Invitae welcomes Bill Osborne to its Board of Directors

– USA, CA –  Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Bill Osborne to its board of directors, effective January 26, 2023.

He will also join the audit committee.

“We are pleased to welcome Bill Osborne to our board of directors and look forward to working with him and taking full advantage of his considerable track record of both operational and governance leadership. Bill has guided multiple companies to achieve transformational growth, scale and innovation, globally,” said CEO, Ken Knight.

He added, “Bill’s experience in the CEO role and his tenure at both Boeing Company and Navistar demonstrate a breadth and depth of leadership within global enterprises. While at Boeing, Bill served in several senior management positions, led its manufacturing council, and provided oversight of corporate environmental health and safety. These roles will offer insight into how companies like ours, in highly competitive industries, can innovate to expand and enhance our service to our patients and customers and streamline processes while fulfilling broader responsibilities to employees and the environment. His perspective and experience from outside the genetics industry will be a valuable addition to our board as we scale our business and bring genetic information into mainstream medicine.”

About William H. Osborne

Mr. Osborne recently retired as SVP of operations and total quality for Boeing Defense, Space & Security (BDS), one of The Boeing Company’s three business units. The Boeing Company is the world’s largest aerospace company and a leading manufacturer of commercial jetliners and defense, space, and security systems. He also maintained oversight of environment, health & safety at BDS, was named to lead Boeing’s manufacturing council, and served on the Boeing executive council.

Before joining Boeing, he was SVP of global manufacturing and quality at Navistar International Corporation, a holding company whose subsidiaries and affiliates produce International® brand commercial and military trucks. Before joining Navistar, he was president and CEO of Federal Signal Corporation, a designer and manufacturer of a suite of products and integrated solutions for municipal, governmental, industrial, and airport customers, from 2008 to 2010.

“Invitae’s focus on making medical genetics affordable, accessible, and ubiquitous has the potential to fundamentally transform healthcare. The company is leading the creation of a new industry, creating a network of patients and their data that may support faster diagnoses, better treatments, and eventually the eradication of disease,” said Bill Osborne. “I’m delighted and grateful for the opportunity to serve the board and the company at this exciting time and look forward to helping the team deliver on its mission to help improve healthcare for billions of people.”

Mr. Osborne currently serves on the board of directors at Quaker Houghton, a global industrial products company where he serves on the compensation, human resources, and sustainability committees; as well as at Armstrong World Industries, a leader in the design, innovation, and manufacture of ceiling and wall system solutions in America, where he serves on the compensation and governance committees.

About Invitae

Invitae is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae’s genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

For more information: https://www.invitae.com/en

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.